Xoma | XOMA - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 82.99M 2.3M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Ardelyx USD 19.24M 845K 2025-12
aTyr Pharma USD 55.07M 51.01M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Curis USD 4.1M 1.01M 2025-06
Eli Lilly USD 5.38B 1.12B 2025-12
Emergent BioSolutions USD 112.2M 500K 2023-12
Incyte USD 1.63B 1.46B 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Prothena USD 5.88M 4.63M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Xoma USD 2.65M 1.52M 2025-09